Today: 4 July 2026
Browse Category

SWX:ROG 22 June 2025 - 7 February 2026

Eli Lilly stock price falls over 2% as Medicare puts Trulicity on 2028 price-talk list

Eli Lilly stock price falls over 2% as Medicare puts Trulicity on 2028 price-talk list

New York, January 27, 2026, 18:39 EST — After-hours Eli Lilly and Company shares ended Tuesday down $24.22, or roughly 2.3%, at $1,039.51. In after-hours trading, the stock edged up about 0.3% to $1,042.50. The U.S. Centers for Medicare & Medicaid Services announced it selected Lilly’s Trulicity, a type 2 diabetes drug, along with 14 other medicines for 2028 price negotiations. This marks the first time the list includes some therapies covered under Medicare Part B. Last year, the agency projected that negotiated prices for the 15 drugs chosen for 2027 would cut annual spending by 36%, roughly $8.5 billion, compared to recent costs.
28 January 2026
·······
Roche stock hovers near a 52-week high as investors brace for Thursday’s results

Roche stock hovers near a 52-week high as investors brace for Thursday’s results

ZURICH, Jan 25, 2026, 17:17 CET — Market closed. Roche Holding participation shares edged up on Friday, hovering near a 52-week high ahead of the Swiss pharma giant’s full-year earnings release this week. The stock closed at 348.10 Swiss francs, gaining 0.06%, after fluctuating between 344.90 and 349.50 during the session, just shy of its one-year peak at 349.70.
25 January 2026
···
Swiss Stock Market Outlook Today (9 December 2025): Roche Catalysts, SNB Rate Bets and Fed Jitters Set the Tone

Swiss Stock Market Outlook Today (9 December 2025): Roche Catalysts, SNB Rate Bets and Fed Jitters Set the Tone

Zurich’s stock market is heading into Tuesday’s session with the Swiss Market Index hovering just under the symbolic 13,000 level, as investors juggle a powerful mix of bullish news from Roche, cautious analyst calls on financials and industrials, and a high‑stakes week for central banks led by the Swiss National Bank and the U.S. Federal Reserve. Below is a structured rundown of what you need to know before the SIX Swiss Exchange opens today.
9 December 2025
Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

Swiss Stock Market Today, 21 November 2025: SMI Holds Near Flat as Tech Slides and Defensives Lift Zurich

The Swiss stock market opened under pressure on Friday but quickly stabilised, with the Swiss Market Index hovering just above the previous day’s close as investors rotated out of high‑flying tech names and into defensive blue chips. By mid‑morning in Zurich, the SMI was trading around 12,553 points, roughly 0.1% higher than Thursday’s close of 12,543, according to intraday data from cash.ch and MarketScreener. cash.ch+2MarketScreener UK+2 That modest gain came after futures had pointed to a drop of nearly three‑quarters of a percent earlier in the morning. finanzen.ch
21 November 2025
······
Record Highs, $55 B Deals & Data Drama: Wall Street’s Wild Week (Oct 4–5, 2025)

EU Stock Market Today (18 November 2025): STOXX 600 Tumbles 1.8% as AI Bubble Fears Rattle European Shares

European equity markets slumped on Tuesday, 18 November 2025, in a broad risk-off move that dragged the pan‑European STOXX 600 to its worst daily loss since August and a one‑month low. Concerns over an overheated AI trade, fading hopes of a near‑term U.S. Federal Reserve rate cut, and fresh policy headlines from Brussels combined to knock sentiment across the EU stock market today. The Economic Times+1 The tone across European bourses was negative from the open, but losses deepened as Wall Street followed suit and U.S. tech names sold off again.
18 November 2025
·····
Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

Tariff Shocks & Rate Jitters Ignite Wild 48 Hours in European Markets

German DAX index graph at the Frankfurt Stock Exchange, reflecting volatile mid-week trading reuters.com. European equities seesawed over the two days, buffeted by transatlantic trade tensions and shifting rate expectations. On Thursday Sept. 25, the STOXX Europe 600 index dropped 0.7%, touching levels not seen in three weeks reuters.com. Almost every major bourse closed in the red reuters.com as traders digested a slew of worrying signals: fresh U.S. trade investigations into high-tech imports, surprisingly robust U.S. economic data, and guarded comments from central bankers. By Friday Sept. 26, however, markets regained footing – the STOXX 600 ticked up roughly +0.3% by midday reuters.com and was on track to finish the eventful week slightly higher brecorder.com. The late-week relief came as investors pivoted to bargain-hunting in financial and industrial shares and awaited key U.S. inflation data for clues on interest rates reuters.com.
26 September 2025
········
Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Top 100 Global Biotechnology Companies Revolutionizing Science and Health

Biotechnology is at the forefront of scientific innovation in 2025, driven by companies around the world that are transforming healthcare, agriculture, and industry. This report profiles 100 of the most important global biotechnology companies selected for their global impact, innovation, revenue, scientific breakthroughs, and sector influence. These companies span biopharmaceutical giants, genomics and diagnostics pioneers, agricultural and environmental biotech leaders, industrial biotech innovators, and key providers of biotech tools and services. Each entry includes the company’s headquarters country, primary sector, notable contributions or innovations, and a link to its official website. The list encompasses both publicly traded and private firms, reflecting the worldwide landscape of biotech innovation. Selection Criteria: Companies were chosen based on their demonstrated leadership or innovation in their field, significant contributions to science and health, financial strength, and influence within their sector. The selection emphasizes current industry positioning and breakthroughs – from life-saving vaccines and therapies to cutting-edge genomic technologies and sustainable biological solutions.
22 June 2025
···········

Stock Market Today

  • Patterson-UTI (PTEN) Slides After Q1 Beat; Water Solutions Tops Peers
    July 3, 2026, 7:05 PM EDT. Oilfield services names turned in uneven Q1 results. The group beat revenue consensus by 3.8% but still averaged a 14.3% drop in share price. Patterson-UTI (NASDAQ:PTEN), with its 135 advanced rigs, posted revenue of $1.12 billion, down 12.7% over last year but 1.2% above analyst targets. PTEN delivered beats on both EPS and EBITDA, yet shares tumbled 19.9% to $8.66 after earnings as investors stuck to worries over low commodity prices. Select Water Solutions (NYSE:WTTR) led on revenue, topping estimates by 6.8%, even as sales dropped 2.3% year-on-year. Oil price swings, tough competition, and the energy transition add to the sector's cloudy near-term picture.
Go toTop